Insights Center

Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.

Featured

Mintz Direct

On our new Mintz Direct page, Mintz thought leaders across industries and practice areas offer timely insights on developments that impact our clients and communities. Visit the Mintz Direct page to hear what our experienced attorneys and professionals are saying about what’s happening now.

Mintz Viewpoints

Use quotation marks to search for an exact phrase (e.g. “class action”)

Published

Showing 5873 - 5880 of 12018 results

The Four Things You Need To Know About The Future of Energy Efficiency

July 23, 2018| Blog| Viewpoint

CMS Focuses on a Modern Medicare

July 23, 2018| Blog| Viewpoint

ML Strategies Weekly Health Care Preview – July 23, 2018

July 23, 2018| Blog| Viewpoint

CMS Proposes to Reduce Payments for New Drugs under Medicare Part B

July 20, 2018| Blog| Viewpoint

Does USCIS Want to Turn Lawful Immigrants into Unlawful, Removable Immigrants? The Answer it seems, is “Yes”

July 20, 2018| Blog| Viewpoint

With its Vanda Pharma and Berkheimer Memos, USPTO Provides Increased Clarity and Predictability in the Patent Eligibility Determination in a Further Boost for Stakeholders and Innovators in Personalized Medicine

July 19, 2018| Advisory| Viewpoint

Special Master Recommends Return of $10.6 Million in Attorneys’ Fees to Class Members

July 19, 2018| Blog| Viewpoint

FDA’s New Biosimilar Action Plan Represents the Next Step for Improving Drug Competition

July 19, 2018| Blog| Viewpoint

News & Press Releases

Mintz Advises on Cogent Biosciences’ $230 Million Public Offering

July 14, 2025

Mintz advised the underwriters in connection with a $230 million public offering by Cogent Biosciences, Inc. of 25,555,556 shares of common stock, which includes 3,333,333 shares issued pursuant to the exercise in full by the underwriters of their option to purchase additional shares of common stock, offered at a public offering price of $9.00 per share. The aggregate gross proceeds to Cogent from this offering were approximately $230 million, including proceeds from the exercise in full by the underwriters of the option to purchase additional shares, before deducting underwriting discounts and commissions and other offering expenses.

Mintz Advises on Soleno Therapeutics’ $200 Million Public Offering

July 14, 2025

Mintz advised the underwriters in connection with a $200 million public offering by Soleno Therapeutics, Inc. of 2,352,941 shares of its common stock at a price to the public of $85.00 per share. The gross proceeds to Soleno from the offering were approximately $200 million before deducting underwriting discounts and commissions and other offering expenses. In addition, Soleno granted the underwriters a 30-day option to purchase up to an additional 352,941 shares of its common stock at the public offering price.

Mintz Advises The Eagle Leasing Company on Acquisition by Rent-A-Container

July 09, 2025

Mintz advised The Eagle Leasing Company, a leading provider of portable storage containers, ground level offices, semi-trailers, and mobile office solutions, in its acquisition by Rent-A-Container (RAC), a portfolio company of Kinderhook Industries, LLC.

View all News and Press Releases